87 related articles for article (PubMed ID: 9198233)
1. The fat mouse: a powerful genetic model to study elevated plasminogen activator inhibitor 1 in obesity/NIDDM.
Samad F; Loskutoff DJ
Thromb Haemost; 1997 Jul; 78(1):652-5. PubMed ID: 9198233
[TBL] [Abstract][Full Text] [Related]
2. Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation.
Alessi MC; Bastelica D; Mavri A; Morange P; Berthet B; Grino M; Juhan-Vague I
Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1262-8. PubMed ID: 12750120
[TBL] [Abstract][Full Text] [Related]
3. Food deprivation induces adipose plasminogen activator inhibitor-1 (PAI-1) expression without accumulation of plasma PAI-1 in genetically obese and diabetic db/db mice.
Oishi K; Ohkura N; Matsuda J; Ishida N
Thromb Haemost; 2007 Oct; 98(4):864-70. PubMed ID: 17938813
[TBL] [Abstract][Full Text] [Related]
4. Elevated expression of transforming growth factor-beta in adipose tissue from obese mice.
Samad F; Yamamoto K; Pandey M; Loskutoff DJ
Mol Med; 1997 Jan; 3(1):37-48. PubMed ID: 9132278
[TBL] [Abstract][Full Text] [Related]
5. Fat cell function and fibrinolysis.
Alessi MC; Morange P; Juhan-Vague I
Horm Metab Res; 2000; 32(11-12):504-8. PubMed ID: 11246816
[TBL] [Abstract][Full Text] [Related]
6. PAI-1 gene 4G/5G polymorphism, cytokine levels and their relations with metabolic parameters in obese children.
Kinik ST; Ozbek N; Yuce M; Yazici AC; Verdi H; Ataç FB
Thromb Haemost; 2008 Feb; 99(2):352-6. PubMed ID: 18278185
[TBL] [Abstract][Full Text] [Related]
7. Differences in plasminogen activator inhibitor 1 in subcutaneous versus omental adipose tissue in non-obese and obese subjects.
He G; Pedersen SB; Bruun JM; Lihn AS; Jensen PF; Richelsen B
Horm Metab Res; 2003 Mar; 35(3):178-82. PubMed ID: 12734779
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor-alpha-induced production of plasminogen activator inhibitor 1 and its regulation by pioglitazone and cerivastatin in a nonmalignant human hepatocyte cell line.
Takeshita Y; Takamura T; Hamaguchi E; Shimizu A; Ota T; Sakurai M; Kaneko S
Metabolism; 2006 Nov; 55(11):1464-72. PubMed ID: 17046548
[TBL] [Abstract][Full Text] [Related]
9. Adipokine and insulin profiles distinguish diabetogenic and non-diabetogenic obesities in mice.
Leiter EH; Reifsnyder PC; Xiao Q; Mistry J
Obesity (Silver Spring); 2007 Aug; 15(8):1961-8. PubMed ID: 17712113
[TBL] [Abstract][Full Text] [Related]
10. Hypofibrinolysis and increased PAI-1 are linked to atherothrombosis via insulin resistance and obesity.
Juhan-Vague I; Alessi MC; Morange PE
Ann Med; 2000 Dec; 32 Suppl 1():78-84. PubMed ID: 11209987
[TBL] [Abstract][Full Text] [Related]
11. Differential mechanisms of plasminogen activator inhibitor-1 gene activation by transforming growth factor-beta and tumor necrosis factor-alpha in endothelial cells.
Chen YQ; Sloan-Lancaster J; Berg DT; Richardson MA; Grinnell B; Tseng-Crank J
Thromb Haemost; 2001 Dec; 86(6):1563-72. PubMed ID: 11776328
[TBL] [Abstract][Full Text] [Related]
12. Altered adipose and plasma sphingolipid metabolism in obesity: a potential mechanism for cardiovascular and metabolic risk.
Samad F; Hester KD; Yang G; Hannun YA; Bielawski J
Diabetes; 2006 Sep; 55(9):2579-87. PubMed ID: 16936207
[TBL] [Abstract][Full Text] [Related]
13. Human visceral adipose tissue and the plasminogen activator inhibitor type 1.
Lindeman JH; Pijl H; Toet K; Eilers PH; van Ramshorst B; Buijs MM; van Bockel JH; Kooistra T
Int J Obes (Lond); 2007 Nov; 31(11):1671-9. PubMed ID: 17471294
[TBL] [Abstract][Full Text] [Related]
14. Fibrinolytic dysfunction in insulin-resistant women with previous gestational diabetes.
Farhan S; Winzer C; Tura A; Quehenberger P; Bieglmaier C; Wagner OF; Huber K; Waldhäusl W; Pacini G; Kautzky-Willer A
Eur J Clin Invest; 2006 May; 36(5):345-52. PubMed ID: 16634839
[TBL] [Abstract][Full Text] [Related]
15. Plasminogen activator inhibitor type 1 (PAI-1) in plasma and adipose tissue in HIV-associated lipodystrophy syndrome. Implications of adipokines.
He G; Andersen O; Haugaard SB; Lihn AS; Pedersen SB; Madsbad S; Richelsen B
Eur J Clin Invest; 2005 Sep; 35(9):583-90. PubMed ID: 16128865
[TBL] [Abstract][Full Text] [Related]
16. The fat mouse. A powerful genetic model to study hemostatic gene expression in obesity/NIDDM.
Loskutoff DJ; Fujisawa K; Samad F
Ann N Y Acad Sci; 2000 May; 902():272-81; discussion 281-2. PubMed ID: 10865847
[TBL] [Abstract][Full Text] [Related]
17. Hyperglycaemic siblings of Type II (non-insulin-dependent) diabetic patients have increased PAI-1, central obesity and insulin resistance compared with their paired normoglycaemic sibling.
Herlihy OM; Barrow BA; Grant PJ; Levy JC
Diabetologia; 2002 May; 45(5):635-41. PubMed ID: 12107743
[TBL] [Abstract][Full Text] [Related]
18. PAI-1 Gene 4G/5G polymorphism and risk of type 2 diabetes in a population-based sample.
Meigs JB; Dupuis J; Liu C; O'Donnell CJ; Fox CS; Kathiresan S; Gabriel SB; Larson MG; Yang Q; Herbert AG; Wilson PW; Feng D; Tofler GH; Cupples LA
Obesity (Silver Spring); 2006 May; 14(5):753-8. PubMed ID: 16855181
[TBL] [Abstract][Full Text] [Related]
19. Hemostatic gene expression and vascular disease in obesity: insights from studies of genetically obese mice.
Samad F; Loskutoff DJ
Thromb Haemost; 1999 Aug; 82(2):742-7. PubMed ID: 10605777
[No Abstract] [Full Text] [Related]
20. Correlation between omental TNF-alpha protein and plasma PAI-1 in obesity subjects.
Cao YL; Wang YX; Wang DF; Meng X; Zhang J
Int J Cardiol; 2008 Aug; 128(3):399-405. PubMed ID: 17698217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
